date,title,source
Oct-17-18,Novartis Q3 Earnings Preview,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,Endocyte's $2.1 Billion Deal Rewards Investors Who Stuck It Out,Bloomberg
Oct-18-18,Novartis to Buy Biopharmaceutical Company Endocyte for $2.1 Billion,GuruFocus.com
Oct-18-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-18-18,FDA snubs Novartis bid to repurpose inflammation drug for heart attacks,Reuters
Oct-18-18,Novartis Reports Positive Long-Term Data From Cosentyx Trials,Zacks
Oct-18-18,Novartis Gets Key Therapy -- For Almost 200 Times Its Last Price,Bloomberg
Oct-18-18,"Why Endocyte, Inc. Stock Is Soaring Today",Motley Fool
Oct-18-18,Novartis Secures Prostate Cancer Treatment With Endocyte Deal,TheStreet.com
Oct-18-18,Novartis To Buy Endocyte In $2.1B Deal,Benzinga
Oct-18-18,[$$] Novartis to Buy Cancer-Drug Maker Endocyte for $2.1 Billion,The Wall Street Journal
Oct-18-18,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",Benzinga
Oct-18-18,Endocyte stock pops 50% on $2.1 bln Novartis acquisition,MarketWatch
Oct-18-18,[$$] European Equities Market Talk Roundup,The Wall Street Journal
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 billion deal,Reuters
Oct-18-18,Novartis: 3Q Earnings Snapshot,Associated Press
Oct-18-18,Novartis pushes deeper into nuclear medicine with $2.1 bln deal,Reuters
Oct-18-18,[$$] European Corporate News Roundup,The Wall Street Journal
Oct-18-18,Endocyte Enters Into Agreement to be Acquired by Novartis for $24/Share,Benzinga
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis to buy cancer drugmaker Endocyte for $2.1 bln in cash,Reuters
Oct-18-18,"Novartis raises 2018 sales outlook as Entresto, Cosentyx accelerate",Reuters
Oct-18-18,Novartis to buy Endocyte for $2.1 billion in cash,Reuters
Oct-18-18,Novartis CEO: No fundamental changes to operations from B...,CNBC Videos
Oct-19-18,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",Benzinga
Oct-19-18,Today's Research Reports on Trending Tickers: Pfizer and Novartis,ACCESSWIRE
Oct-19-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-22-18,"Novartis (NVS) Q3 Earnings In Line, Revenues Beat Estimates",Zacks
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,This tiny biotech spun a quick $2 billion from $12 million,MarketWatch
Oct-23-18,"Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT",Zacks
Oct-25-18,"Bulls bet this financial name is set to bounce. Plus, the...",CNBC Videos
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Drugmakers tout new medicines as eye disease battle intensifies,Reuters
Oct-29-18,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters
Oct-30-18,Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower,Motley Fool
Oct-30-18,Incyte Corp (INCY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,GlaxoSmithKline plc (GSK) Q3 Earnings Conference Call Transcript,Motley Fool
Oct-31-18,Premier Bay Area biotech developer tees up next major project,American City Business Journals
Oct-31-18,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",Zacks
Oct-31-18,FDA approves Novartis' copy of AbbVie bestseller Humira,Reuters
Oct-31-18,"Amgen (AMGN) Beats on Earnings & Sales in Q3, Raises View",Zacks
Oct-31-18,"Glaxo (GSK) Beats Earnings Estimates in Q3, Revenue In-line",Zacks
Nov-01-18,Gene therapy: CHOP unveils $75M manufacturing facility (Photos),American City Business Journals
Nov-02-18,Novartis abandons effort for U.S. approval of biosimilar rituximab,Reuters
Nov-02-18,Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology,PR Newswire
Nov-02-18,"Conatus' (CNAT) Q3 Loss In Line, Revenues Lag Estimates",Zacks
Nov-05-18,"4 months after drug approval, Achaogen eyes fire sale",American City Business Journals
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,What Lies in Store for Ligand (LGND) This Earnings Season?,Zacks
Nov-07-18,This Rockville biotech is expanding to a new HQ. Here are the details.,American City Business Journals
Nov-07-18,Amgen (AMGN) Counts on New Drugs Amid Rising Biosimilar Woes,Zacks
Nov-08-18,Novartis division Sandoz recalls one lot of blood pressure drug,Reuters
Nov-08-18,Ligand Pharmaceuticals Inc (LGND) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Nov-09-18,"Ligand (LGND) Beats on Q3 Earnings & Revenues, Raises View",Zacks
Nov-12-18,Tilray (TLRY) to Report Q3 Earnings: What's in the Cards?,Zacks
Nov-12-18,These Biopharmas Could Cure Genetic Diseases  At $5 Million Apiece,Investor's Business Daily
Nov-14-18,Migraine-Focused Biotech Has A Headache On Quarterly Losses,Investor's Business Daily
Nov-14-18,Novartis AG (NVS) Not Doing Enough to Attract Smart Money,Insider Monkey
Nov-15-18,Novartis launches third-to-market Remicade copy in Germany,Reuters
Nov-15-18,"The Zacks Analyst Blog Highlights: Chevron, Novartis, Qualcomm, TJX and Deere",Zacks
Nov-15-18,"Novartis 'completely committed' to Sandoz, has no split-off plan",Reuters
Nov-15-18,"Novartis says 'completely committed' to Sandoz, not planning split-off",Reuters
Nov-16-18,Novartis' blood disorder drug gets FDA approval for expanded use,Reuters
Nov-16-18,Alphabet unit halts glucose-detecting contact lens project,Reuters
Nov-19-18,[$$] Novartis CEO Bets on Cutting-Edge Science to Remake Drug Giant,The Wall Street Journal
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
Nov-20-18,CYRX: Q3 Another Very Strong Quarter With New Records in Several Categories. Operating Leverage Continues To Solidify,Zacks Small Cap Research
Nov-20-18,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",Benzinga
Nov-21-18,This Highly Rated Pharma Giant Is More Than Just A Diabetes Player,Investor's Business Daily
Nov-23-18,US benefits manager baulks after Novartis values gene therapy at $4-5 mln,Reuters
Nov-23-18,"Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs",Zacks
Nov-23-18,Novartis's pricing might be tested with costly eye therapy,Reuters
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-23-18,U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million,Reuters
Nov-26-18,Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss,Zacks
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,Novartis CEO: 4 factors can help the industry price and pay for lifesaving cell and gene therapies,CNBC
Nov-26-18,4 Reasons Why Lilly is Up More Than 30% This Year So Far,Zacks
Nov-26-18,European approval of Spark Therapeutics' gene therapy triggers $25M payment,American City Business Journals
Nov-27-18,Roche buys U.S. biotech Jecure in race for liver disease drugs,Reuters
Nov-27-18,Novartis's Alcon sees myopia epidemic driving sales growth,Reuters
Nov-27-18,3 Reasons Why Glaxo (GSK) Stock is Up This Year So Far,Zacks
Nov-28-18,Novartis (NVS) Receives EC Approval for Neulasta Biosimilar,Zacks
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Novartis' Biosimilar to Amgen's Neulasta Approved in Europe,GuruFocus.com
Nov-28-18,Novartis joins rush of science companies moving to White City,Evening Standard
Nov-28-18,"Glaxo's Horlicks Sale Bid Heats Up, Nestle, Unilever Close In",Zacks
Nov-29-18,Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,4 Big Pharma Stocks to Add to Your Portfolio in December,Zacks
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Novartis' Gilenya Approved in EU for Expanded Population,Zacks
Nov-30-18,Novartis CEO Has One New Breakthrough Drug: It Costs $4 Million,Meredith Videos
Dec-03-18,UPDATE 1-High-cost Gilead cell therapy proves durable for some lymphoma patients,Reuters
Dec-03-18,Novartis SMA treatment could get FDA approval in May,Reuters
